CochranLab retweeted
Congratulations to Professor Jennifer Cochran @CochranLab who was recently elected to the National Academy of Engineering @theNAEng for protein discovery and development, biotechnology entrepreneurship, and leadership in academic bioengineering!
news.stanford.edu/stories/20…
CochranLab retweeted
I'm excited to share our work "Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function" that's now out in PNAS! 1/3
Link to paper: pnas.org/doi/10.1073/pnas.23…
Link to press release: news.stanford.edu/2024/03/11…
CochranLab retweeted
#JI_TopRead from @CaitlynBioE @CochranLab @CarolynBertozzi @StanfordHealth | #TLR9 agonist, PIP-CpG, enhances the CD8 #Tcell response to spontaneous tumors | #ReadTheJI #immunology #AuthorChoice #FreetoRead #TumorImmunology
👉 ow.ly/FTbV50P6FNv
CochranLab retweeted
In the physiologically relevant MMTV-PyMT GEMM model, @CaitlynBioE @BarfiIdit @CarolynBertozzi demonstrated that systemic delivery of a tumor integrin-targeted TLR9 agonist (PIP-CpG) led to sustained elimination [...] bit.ly/3Cu9QTC
CochranLab retweeted
Thrilled to announce that our new PIP-CpG paper is now live @J_Immunol . PIP-CpG is a tumor-targeting immunotherapy that is in preclinical development & we are hoping to advance it to the clinic in the coming years. doi.org/10.4049/jimmunol.220… .
A 🧵👇(1/13)
CochranLab retweeted
Wonderful insights and leadership from @Stanford @StanfordMed @CochranLab @KarlDeisseroth @drcwestphal
#Longwoodhealthcareleaders
CochranLab retweeted
Congratulations to faculty fellows @alaurenoconnell, @CyertMartha & Jennifer Cochran @CochranLab for winning the 2022 @StanfordMedOFDD Faculty Women’s Forum Awards!
Learn more: stanford.io/3zt8wQz
CochranLab retweeted
Immensely enjoyed the reviewing experience and spending the day-and-a-half on @Stanford campus with this special group of people @kumarlabucb @Widya__Mulya @chubaoyolu @TejalADesai and Darelene Soloman of @Agilent. Thank you @StanfordBioE @CochranLab for the hospitality!
Honored to serve on the External Review Committee for @StanfordBioE last week! Inspiring dept, brilliantly led by @CochranLab. Plus the views are pretty nice... Joined by @Widya__Mulya, @chubaoyolu, and @raviradhak, along w @TejalADesai and Darlene Solomon (not shown). 🌲
CochranLab retweeted
Join #PEGS22 Plenary Keynote Jennifer Cochran, PhD, today at 4:10pm to discuss challenges and opportunities in developing non-antibody protein therapeutics. pegsummit.com/plenary-keynot…
CochranLab retweeted
TLR9 (CpG) agonist was chemically conjugated to polyspecific integrin-binding peptide (PIP) that is capable to localise various types of solid tumours as explained by Caitlyn Miller from @CochranLab at @Stanford #PEGS22 @PEGSboston
CochranLab retweeted
Read Jennifer Cochran's recent @CellChemBiol article: Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression @CochranLab #AACR22 hubs.li/Q017Kf5f0
CochranLab retweeted
Happy to share our lab's first manuscript. In work led by @JTheruvath_MD, we tested a combo of FDA approved anti-GD2 with blockade of CD47, a macrophage checkpoint. Blocking CD47 unleashes patients' macrophages to phagocytose or 'eat' cancer cells. Combo was highly effective! 1/
📢 New in @NatureMedicine! Great work led by @Majzner_Lab @JTheruvath_MD shows that the combo of anti-GD2 + CD47 blockade ⬆️ anti-tumor activity in 🐭 models of #neuroblastoma, #osteosarcoma & #lungcancer by modulating #macrophage activity #immunotherapy nature.com/articles/s41591-0…
CochranLab retweeted
#AACR21 Attending today's session on Paracrine Signaling in Cancer? Check out this article by chair Jennifer Cochran @CochranLab published in @CommsBio this week! nature.com/articles/s42003-0…
CochranLab retweeted
Hunter et al. engineered a high affinity, soluble variant of leukemia inhibitory factor receptor (LIFR) to trap the LIF cytokine and prevent further signaling as a therapeutic strategy. @CochranLab @StanfordBioE @stanfordcbio @StanfordMed @salkinstitute
nature.com/articles/s42003-0…
CochranLab retweeted
We are very excited to introduce you, the next speaker of the #affinity2021 #conference: Prof. Jennifer Cochran, the PI at the @CochranLab from @StanfordBioE. For more information about important dates and registration click here 👉 affinity2021.org
CochranLab retweeted
When the pandemic hit, @CochranLab jumped on the opportunity to fire crystals on SLAC’s new beam line as part of our #COVID19 research. Rather than target the virus directly, my work focuses on modulating the immune system to fight this new disease.
Check out the feature here:
In the middle of the pandemic, SLAC's Stanford Synchrotron Radiation Lightsource started up a new beam line. Their efforts are already helping SARS-CoV-2 researchers better understand the virus. stanford.io/30pB37O
CochranLab retweeted
Hats off to Stanford immunology professors Scott Boyd, Jennifer Cochran, and Peter Kim, and professor of structural biology professor Ted Jardetzky who collaborated to develop an antibody test for COVID-19 stanforddaily.com/2020/06/09…
CochranLab retweeted
Our new nanoluc substrate paper is online! If you are using NanoLuc-based reporter for your in vivo application, you could try this out to boost the signal while lowering the toxicity. Thanks @promega for the fantastic collaboration and thanks @michaelzlin for the mentoring.
Excited to announce our new work @naturemethods on improving bioluminescence imaging in vivo (good for seeing cancer or infections). A great collaboration with our friends at @promega and Stanford. Last experiment done on shutdown day😉
full text: rdcu.be/b5AwD
CochranLab retweeted
Check out our new collaborative paper with the @CochranLab and Woo lab!
sciencedirect.com/science/ar…
CochranLab retweeted
New study led by Alejandro Sweet-Cordero & Jennifer Cochran shows first-in-class engineered receptor decoy against CLCF1/CNTFR signaling exhibits anti-tumor activity in pre-clinical models of #lungcancer nature.com/articles/s41591-0… #LungCancerAwarenessMonth #drugdiscovery #Cancer
